Record #33082

Second or third additional chemotherapy drug for non‐small cell lung cancer in patients with advanced disease (Pub 2)

Citation lifecycle

How this paper is being cited

Pre-retraction
16
Same day
0
Post-retraction
21
% post-retraction
56.8%
~3.6 citations/yr before retraction · ~1.5 citations/yr after
citing papers

Who is still citing this work

Loading…